Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China SFDA Vows To Find, Prosecute ‘Made In India’ Chinese Drug Makers

This article was originally published in PharmAsia News

Executive Summary

China's State FDA says it will investigate allegations that some drugs are being made in China for sale abroad and labeled "Made in India." The action stemmed from anti-malaria drugs seized by Nigeria's Drug Regulatory Authority, enough to treat 642,000 adults. An SFDA spokesperson said the agency is sending investigators to Chinese provinces where the drugs allegedly were made. Another official said the guilty companies would be prosecuted, but advised pharmacy companies in other countries to deal only with Chinese firms recognized by SFDA. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts